NO-ceuticals

NO-ceuticals B.V. is a Netherlands-based biotechnology startup dedicated to optimizing human health, performance, and longevity through microbiome-driven nitric oxide (NO) solutions. Founded by a team with roots in medicine, the company leverages a patented ingredient called Qinino®, which is designed to enhance the bacterial nitric oxide route. By activating nitrate-converting bacteria throughout the body, rather than just in the mouth, the technology aims to boost both local and systemic nitric oxide production. The company operates as a remote-first organization and focuses on science-backed innovation to develop natural and effective health solutions.

The company’s work is significant for individuals and partners seeking advanced, evidence-based approaches to wellness and metabolic health. By focusing on the body's own mechanisms for nitric oxide generation, NO-ceuticals addresses a critical component of physiological health. The startup is currently engaged in ongoing research and development, with initial studies yielding promising results. They are actively building a strategic framework for future clinical validation and commercial application, while seeking collaborations with research and innovation partners to bring their proprietary ingredients to a global market.